Jocelyn Lorenzo
Neurology with Special Qualifications in Child Neurology · Baton Rouge, LANPI 1265883375
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 20.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $928, 5.1 times the $182 reported in 2022. That places this record below the midpoint for neurology with special qualifications in child neurology clinicians in LA, where the typical reported total is $5,367.
Across 107 payments — averaging $24.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Jazz Pharmaceuticals Inc.$539
- UCB, Inc.$384
- Neurelis, Inc.$322
- Biogen$295
- Genentech USA, Inc.$242
- Livanova USA, Inc.$219
- plus $622 from 14 others
What the payments were for
- Food & beverage$2,623100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Jazz Pharmaceuticals Inc. | 24 | $539 |
| UCB, Inc. | 17 | $384 |
| Neurelis, Inc. | 9 | $322 |
| Biogen | 13 | $295 |
| Genentech USA, Inc. | 12 | $242 |
| Livanova USA, Inc. | 5 | $219 |
| Supernus Pharmaceuticals, Inc. | 5 | $97 |
| Acadia Pharmaceuticals Inc | 5 | $91 |
| Immedica Pharma US, Inc. | 3 | $77 |
| Biocodex, Inc. | 1 | $73 |
| Upsher-smith Laboratories LLC | 2 | $60 |
| Corium, LLC | 3 | $52 |
| Sarepta Therapeutics, Inc. | 1 | $34 |
| Novartis Gene Therapies, Inc. (fka Avexis, Inc.) | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $26 |
| AstraZeneca | 1 | $23 |
| Ironshore Pharmaceuticals Inc. | 1 | $21 |
| Eisai Inc. | 1 | $18 |
| Collegium Pharmaceutical, Inc. | 1 | $13 |
| Aucta Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,623 in reported general payments places this provider in the 35th percentile of 30 neurology with special qualifications in child neurology providers in Louisiana.
See all neurology with special qualifications in child neurology providers in Louisiana →
Other neurology with special qualifications in child neurology in Baton Rouge
- Shannon McGuireBaton Rouge$10K
- Yash ShahBaton Rouge$9K
- Lalania SchexnayderBaton Rouge$2K
- Chad ManuelBaton Rouge$2K
- Thomas EnlowBaton Rouge$2K
- Aristotel Pena-MichesMonroe$207K
- Ann Henderson TiltonNew Orleans$119K
- Cresha DavisWest Monroe$73K
- Joaquin WongNew Orleans$28K
- Allison ConraveyNew Orleans$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.